ArticleScientific reports2025
Transfer learning prediction of type 2 diabetes with unpaired clinical and genetic data.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Application of AI and digital health tools in public health management of T2DM: from mechanism prediction to personalized treatment.Frontiers in public health · 2026Review
- Leveraging XGBoost and explainable AI for accurate prediction of type 2 diabetes.BMC public health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The prevalence of type 2 diabetes mellitus (T2DM) in Korea has risen in recent years, yet many cases remain undiagnosed. Advanced artificial intelligence models using multi-modal data have shown promise in disease prediction, but two major challenges persist: the scarcity of samples containing all desired data modalities and class imbalance in T2DM datasets. We propose a novel transfer learning framework to predict T2DM onset within five years, using two Korean cohorts (KoGES and SNUH). To utilize unpaired multi-modal data, our approach transfers knowledge between clinical and genetic domains, leveraging unpaired clinical data alongside paired data. We also address class imbalance by applying a positively weighted binary cross-entropy (BCE) loss and a weighted random sampler (WRS). The transfer learning framework improved T2DM prediction performance. Using WRS and weighted BCE loss increased the model's balanced accuracy and AUC (achieving test AUC 0.8441). Furthermore, combining transfer learning with intermediate data fusion yielded even higher performance (test AUC 0.8715). These enhancements were achieved despite limited paired multi-modal samples. Our framework effectively handles scarce paired data and class imbalance, leading to improved T2DM risk prediction. This approach can be adapted to other medical prediction tasks and integrated with additional data modalities, potentially aiding earlier diagnosis and better disease management in clinical settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.